2.No Title.
Do Young CHUNG ; Young Soo KIM
Journal of the Korean Continence Society 1997;1(1):53-53
No abstract available.
3.Clinical evaluation of a totally implantable venous access system for long-term anticancer chemotherapy.
Tejune CHUNG ; Won Sang CHUNG ; Young Hak KIM
Journal of the Korean Cancer Association 1991;23(2):424-428
No abstract available.
Drug Therapy*
4.Effects of glutamate and glycine on the binding of 3HMK-801 to the N-Methyl-K-Aspartate receptor in rat brain.
Young In CHUNG ; Young Hoon KIM ; Myung Jung KIM
Journal of Korean Neuropsychiatric Association 1993;32(4):545-553
No abstract available.
Animals
;
Brain*
;
Glutamic Acid*
;
Glycine*
;
Rats*
5.Detection of genital herpes infection by culturing herpes simplex virus and immunofluorecent stain.
Korean Journal of Obstetrics and Gynecology 1992;35(9):1324-1336
No abstract available.
Herpes Genitalis*
;
Herpes Simplex*
;
Simplexvirus*
6.A clinical review of early gastric cancer.
Journal of the Korean Surgical Society 1992;43(3):321-329
No abstract available.
Stomach Neoplasms*
7.A clinical analysis of 72 renal transplantations.
Sang Young CHUNG ; Shin Kon KIM
The Journal of the Korean Society for Transplantation 1991;5(1):17-26
No abstract available.
Kidney Transplantation*
8.A clinical analysis of 72 renal transplantations.
Sang Young CHUNG ; Shin Kon KIM
The Journal of the Korean Society for Transplantation 1991;5(1):17-26
No abstract available.
Kidney Transplantation*
9.Analysis of prognositic factors and long-term survival according to the pattern of lymph node metastasis in surgically resected N2 Non-Small cell lung cancer(NSCLC).
Tuberculosis and Respiratory Diseases 2000;49(4):474-485
BACKGROUND: Current studies on multimodal strategy for N2 non-small cell lung cancer are being high interest have drawn much attention. N2 lung cancer, however, is composed of is divided into several subgroups with that have different prognoses. The prognostic factors still ramain controversial. METHODS: Between January 1990 and June 1999, 180 patients with N2 lung cancer who underwent surgical resection were investigated, excluding 10 of these for surgical mortality. All patients underwent mediastinal lymph node dissection. 20 clinicopathologic factors were investigated by univariable and multivariable analyses to identify significant prognostic factors among resected N2 disease. RESULTS: The overall 5-year survival rate was 20.6%. Multivariable analyses among overall patients revealed 3 significant prognostic factors:Age, Histologic type, Vascular invasion. Based on the result, 49 patients with both age more than 60 and pathologic Non-squamous cell showed a 5-year survival of 5.0%, whereas 37 patients with neither of the factors showed a 5-year survival of 56.6%(p<0.001). And 12 patients with both vascular invasion and pathologic Non-squamous cell showed a 5-year survival of 11.9%, whereas 67 patients with neither of the factors showed a 5-year survival of 33.6%(p=0.01). CONCLUSION: The prognosis of surgically resected N2 disease varies according to the 2 significant prognosis factors. Tumor size may be an additional influencing factor in the prognosis of N2 disease.
Carcinoma, Non-Small-Cell Lung
;
Humans
;
Lung Neoplasms
;
Lung*
;
Lymph Node Excision
;
Lymph Nodes*
;
Mortality
;
Neoplasm Metastasis*
;
Prognosis
;
Survival Rate
10.Portal hypertension in children.
Journal of the Korean Pediatric Society 1992;35(11):1528-1536
No abstract available.
Child*
;
Humans
;
Hypertension, Portal*
Result Analysis
Print
Save
E-mail